|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Real Estate | ||||||||||||||||||||
| Land | ||||||||||||||||||||
| Building and Improvements | ||||||||||||||||||||
| Total Real Estate | ||||||||||||||||||||
| Less Accumulated Depreciation | ||||||||||||||||||||
| Net Real Estate | ||||||||||||||||||||
| Real Estate Held for Sale | ||||||||||||||||||||
| Cash and Cash Equivalents | ||||||||||||||||||||
| In-Place Lease Intangible Assets, net | ||||||||||||||||||||
| Loan Receivable, net (Current Expected Credit Loss of $51 and $71, respectively) | ||||||||||||||||||||
| Other Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Equity: | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Accounts Payable and Accrued Expenses | ||||||||||||||||||||
| Revolving Credit Facility | ||||||||||||||||||||
| Loan Payable, net | ||||||||||||||||||||
| Dividends and Distributions Payable | ||||||||||||||||||||
| Security Deposits | ||||||||||||||||||||
| Rent Received in Advance | ||||||||||||||||||||
| Other Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Preferred Stock, $0.01 Par Value, 100,000,000 Shares Authorized, 0 Shares Issued and Outstanding, respectively | ||||||||||||||||||||
| Common Stock, $0.01 Par Value, 400,000,000 Shares Authorized, 20,580,766 and 20,552,632 Shares Issued and Outstanding, respectively | ||||||||||||||||||||
| Additional Paid-In Capital | ||||||||||||||||||||
| Accumulated Deficit | ||||||||||||||||||||
| Total Stockholders' Equity | ||||||||||||||||||||
| Noncontrolling Interests | ||||||||||||||||||||
| Total Equity | ||||||||||||||||||||
| Total Liabilities and Equity | ||||||||||||||||||||
| Preferred Stock, Shares Issued (in shares) | ||||||||||||||||||||
| Preferred Stock, Shares Outstanding (in shares) | ||||||||||||||||||||
Loading...
